Asset Details
Do you wish to reserve the book?
Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
Do you wish to request the book?
Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
2014
Overview
Background:
Securing a diagnosis of ovarian cancer and establishing means to predict outcomes to therapeutics remain formidable clinical challenges. Early diagnosis is particularly important since survival rates are markedly improved if tumour is detected early.
Methods:
Comprehensive miRNA profiles were generated on presurgical plasma samples from 42 women with confirmed serous epithelial ovarian cancer, 36 women diagnosed with a benign neoplasm, and 23 comparably age-matched women with no known pelvic mass.
Results:
Twenty-two miRNAs were differentially expressed between healthy controls and the ovarian cancer group (
P
<0.05), while a six miRNA profile subset distinguished presurgical plasma from benign and ovarian cancer patients. There were also significant differences in miRNA profiles in presurgical plasma from women diagnosed with ovarian cancer who had short overall survival when compared to women with long overall survival (
P
<0.05).
Conclusion:
Our preliminary data support the utility of circulating plasma miRNAs to distinguish women with ovarian cancer from those with a benign mass and identify women likely to benefit from currently available treatment for serous epithelial ovarian cancer from those who may not.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ Adult
/ Aged
/ Biological and medical sciences
/ Biomarkers, Tumor - genetics
/ Biomedical and Life Sciences
/ Carcinoma, Ovarian Epithelial
/ Female
/ Gynecology. Andrology. Obstetrics
/ Humans
/ Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
/ Neoplasms, Glandular and Epithelial - blood
/ Neoplasms, Glandular and Epithelial - genetics
/ Neoplasms, Glandular and Epithelial - mortality
/ Oncology
/ Ovarian Neoplasms - genetics
/ Ovarian Neoplasms - mortality
/ Survival
/ Tumors
